Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

The article continued: Recently Spotify's founder Daniel Ek's new HealthTech startup Neko Health secured a $260 million financing, valuing the company at approximately $1.8 billion. As part of the ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Detailed price information for Structure Therapeutics Inc (GPCR-Q) from The Globe and Mail including charting and trades.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

BMO Capital Markets affirmed their positive stance on Novo Nordisk (NYSE:NVO) stock, maintaining both their Outperform rating and a $105.00 price target. The endorsement comes in the wake of promising ...

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

Shares of Schrödinger soared by 15% mid-day Tuesday as the company, known for leveraging quantum mechanics in medicine and material design, embraces artificial intelligence (AI) to enhance its drug ...

Meeting is thrilled to announce that Morten Meldal, Nobel Laureate and Professor of Chemistry at the University of Copenhagen ...

This year, I predict we will witness an uptick in both early and late-stage asset acquisitions, like Eli Lilly ... (AI) continues to dominate headlines, and its role in drug development is ...